Growth Metrics

Cellectis (CLLS) Change in Working Capital (2014 - 2026)

Cellectis (CLLS) posted Change in Working Capital of $611000.0 for Q1 2026, up 101.52% on a QoQ basis from -$40.2 million in Q3 2025, and up 105.45% year-over-year from $297401.6 in Q1 2025.

Cellectis (CLLS) has 13 years of Change in Working Capital data on file, last reported at $611000.0 in Q1 2026.

  • In Q1 2026, Change in Working Capital rose 105.45% year-over-year to $611000.0; the TTM figure through Mar 2026 stood at $611000.0 (up 105.45% YoY), while the FY2025 annual figure was $41.6 million, up 177.5% from the prior year.
  • Change in Working Capital advanced to $611000.0 in Q1 2026, from -$40.2 million in the prior quarter.
  • Across five years, Change in Working Capital topped out at $52.1 million in Q2 2024 and bottomed at -$40.2 million in Q3 2025.
  • A 5-year average of -$2.5 million and a median of -$8.9 million in 2024 frame the typical range for Change in Working Capital.
  • Annual changes were most pronounced in 2024 — Change in Working Capital jumped 577.46% — and 2025, when it slumped 183.09%.
  • Year by year, Change in Working Capital stood at -$6.7 million in 2022, then sank by 52.62% to -$10.2 million in 2023, then soared by 575.34% to $48.4 million in 2024, then slumped by 183.09% to -$40.2 million in 2025, then surged by 101.52% to $611000.0 in 2026.
  • The last three Change in Working Capital figures came in at $611000.0 (Q1 2026), -$40.2 million (Q3 2025), and -$23.5 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Working Capital (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -
10 Cellectis 20.83 Bn 20.62 Bn - 611,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 611,000.00
Mar 31, 2026 611,000.00
Sep 30, 2025 -40.22 Mn
Sep 30, 2025 -40.22 Mn
Jun 30, 2025 -23.49 Mn
Jun 30, 2025 -23.49 Mn
Mar 31, 2025 -11.22 Mn
Mar 31, 2025 -11.22 Mn
Sep 30, 2024 48.40 Mn
Sep 30, 2024 48.40 Mn
Jun 30, 2024 52.12 Mn
Jun 30, 2024 52.12 Mn
Mar 31, 2024 -8.89 Mn
Mar 31, 2024 -8.89 Mn
Sep 30, 2023 -10.18 Mn
Sep 30, 2023 -10.18 Mn
Jun 30, 2023 -10.92 Mn
Jun 30, 2023 -10.92 Mn
Mar 31, 2023 -10.33 Mn
Mar 31, 2023 -10.33 Mn
Sep 30, 2022 -6.67 Mn
Sep 30, 2022 -6.67 Mn
Jun 30, 2022 -4.69 Mn
Jun 30, 2022 -4.69 Mn
Mar 31, 2022 -7.56 Mn
Mar 31, 2022 -7.56 Mn
Sep 30, 2021 9.80 Mn
Sep 30, 2021 9.80 Mn
Jun 30, 2021 10.56 Mn
Jun 30, 2021 10.56 Mn
Mar 31, 2021 -9.71 Mn
Mar 31, 2021 -9.71 Mn
Sep 30, 2020 -20.00 Mn
Sep 30, 2020 -20.00 Mn
Jun 30, 2020 -16.67 Mn
Jun 30, 2020 -16.67 Mn
Mar 31, 2020 -20.32 Mn
Mar 31, 2020 -20.32 Mn
Sep 30, 2019 -12.19 Mn
Sep 30, 2019 -12.19 Mn
Jun 30, 2019 -5.99 Mn
Jun 30, 2019 -5.99 Mn
Mar 31, 2019 -8.26 Mn
Mar 31, 2019 -8.26 Mn
Sep 30, 2018 -7.86 Mn
Sep 30, 2018 -7.86 Mn
Jun 30, 2018 -11.33 Mn
Jun 30, 2018 -11.33 Mn
Mar 31, 2018 -8.59 Mn
Mar 31, 2018 -8.59 Mn
Sep 30, 2017 -19.75 Mn
Sep 30, 2017 -19.75 Mn
Jun 30, 2017 -15.47 Mn
Jun 30, 2017 -15.47 Mn
Mar 31, 2017 -10.58 Mn
Mar 31, 2017 -10.58 Mn
Sep 30, 2016 -34.93 Mn
Sep 30, 2016 -34.93 Mn
Jun 30, 2016 -32.22 Mn
Jun 30, 2016 -32.22 Mn
Mar 31, 2016 -15.15 Mn
Mar 31, 2016 -15.15 Mn
Dec 31, 2015 770,570.45
Dec 31, 2015 770,570.45
Sep 30, 2015 -12.99 Mn
Sep 30, 2015 -12.99 Mn
Jun 30, 2015 -11.16 Mn
Jun 30, 2015 -11.16 Mn
Mar 31, 2015 2.16 Mn
Mar 31, 2015 2.16 Mn
Dec 31, 2014 -1.23 Mn
Dec 31, 2014 -1.23 Mn